MedPath
FDA Approval

Brevibloc

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
June 15, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Esmolol(10 mg in 1 mL)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

SYNGENE INTERNATIONAL LIMITED

Baxter Healthcare Corporation

915833842

Baxter Healthcare Corporation

Baxter Healthcare Corporation

001728059

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Brevibloc

Product Details

NDC Product Code
10019-115
Application Number
NDA019386
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
April 1, 2014
EsmololActive
Code: V05260LC8DClass: ACTIBQuantity: 10 mg in 1 mL
SODIUM ACETATEInactive
Code: 4550K0SC9BClass: IACTQuantity: 2.8 mg in 1 mL
ACETIC ACIDInactive
Code: Q40Q9N063PClass: IACTQuantity: 0.546 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 5.9 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT

Brevibloc

Product Details

NDC Product Code
10019-075
Application Number
NDA019386
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
April 1, 2014
SODIUM ACETATEInactive
Code: 4550K0SC9BClass: IACTQuantity: 2.8 mg in 1 mL
EsmololActive
Code: V05260LC8DClass: ACTIBQuantity: 20 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 4.1 mg in 1 mL
ACETIC ACIDInactive
Code: Q40Q9N063PClass: IACTQuantity: 0.546 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT

Brevibloc

Product Details

NDC Product Code
10019-055
Application Number
NDA019386
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
April 1, 2014
SODIUM ACETATEInactive
Code: 4550K0SC9BClass: IACTQuantity: 2.8 mg in 1 mL
EsmololActive
Code: V05260LC8DClass: ACTIBQuantity: 10 mg in 1 mL
ACETIC ACIDInactive
Code: Q40Q9N063PClass: IACTQuantity: 0.546 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 5.9 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath